Biotech & Life Sciences

Sergio Botero is both a strategist and a scientist bringing a broad range of scientific and engineering expertise to Atoll by bridging technical and financial aspects of projects. Sergio’s academic background started with two Bachelors of Science degrees, in Biology and Microbiology, and a Master of Science degree in Biological Sciences with emphasis on Ecology and Primatology, all at Universidad de los Andes in his home country of Colombia.  >>>​

Rita Marreiros, Ph.D. is an ambitious neuroscientist and life science consultant with a diverse background spanning academia, biotech, and non-profit sectors. Her career began with a postdoctoral fellowship in a Nobel Prize laureate setting the stage for a career dedicated to driving innovation and translating cutting-edge research into impactful therapeutic solutions.​ >>>>​​​​​​​​

Nicolas Velez is a current postdoctoral research fellow working at the Institute of Regenerative Medicine at the Icahn School of Medicine in Mount Sinai. His work focuses on the intersection between neural circuitry integrity and immunity in diseases like Alzheimer’s disease and multiple sclerosis. For his research he employs a gamut of experimental and computational techniques, going from synthetic biology, to genomics and AI, to study neuroimmune interactions in patient-derived tissue.   >>>>​​​​

Akash Sookdeo is a genome engineer and computational biologist with deep expertise spanning solid tumor oncology, AI-driven protein engineering, CRISPR gene editing, and biotech venture development. He is dedicated to bridging rigorous science with real-world therapeutic and investment impact. >>>>​​​​​​​​

As Managing Director of Capital Markets, Jonathan Hakala brings a wealth of senior financial, managerial and board-level experience to this leadership position helping to oversee capital markets activities for the Atoll Financial Group. Jonathan's senior financial, managerial and board-level expertise helps the Atoll Financial Group team pursue the best possible financial solutions for our clients. >>>

​

​

José Estabil is a connector and technology innovator in the life sciences. His recent executive roles focus on AI-assisted precision medicine. José translated cutting edge genomics and optics into profitable molecular diagnostics (Cipherome), chip diagnostics (KLA), and semiconductor devices (IBM) that resulted in reducing the risk of leg amputations, cost-effective semiconductor manufacturing, and faster circuits, respectively. >>>>

​​​​

Lauren Dierdorff is a Ph.D. candidate in Neuroscience at the Icahn School of Medicine at Mount Sinai, conducting translational research in the De Rubeis lab within the Seaver Autism Center for Research and Treatment and Department of Psychiatry. Her work focuses on the cortical circuits underlying motor deficits in a model of DDX3X syndrome, a rare genetic neurodevelopmental disorder.  >>>>

​​​​​​​​​

​

​

Alejandro is a Postdoctoral Fellow at the Castellano Lab, in the Department of Neuroscience at the Icahn School of Medicine at Mount Sinai, where he investigates the application of cellular and molecular mechanisms underlying brain rejuvenation to Alzheimer’s disease. His work, funded by the Alzheimer’s Association, focuses on how extracellular matrix remodeling and astrocyte interactions influence amyloid pathology, contributing to our understanding of neurodegenerative processes. >>>>​​​​​​​​

Brianna Berrios is a PhD Candidate at NYU Langone in the Institute for Systems Genetics. Her work investigates the genetic regulation of an evolutionarily conserved gene crucial to proper eye and central nervous system development.​ Her work is ultimately motivated by learning how genetic information is integrated to obtain a coherent output and how developmental processes can provide insight to regenerative medicines.  >>>>​​​​​​​

​

A visionary and veteran of the financial industry, JJ Carrasco established Atoll Financial Group to meet the unique needs of businesses looking for innovative structured project finance and other complex financing alternatives. As Managing Partner, JJ is responsible for the overall company strategy and management of all business processes, strategic partnerships, product development and market feasibility analysis, staffing, and more.  >>>

Mohammed Mostajo-Radji is an Assistant Research Scientist at the Genomics Institute of the University of California, Santa Cruz (UCSC), where his lab is part of the Braingeneers group, a multidisciplinary collective of geneticists, neuroscientists, and engineers focused on understanding the specification and function of the human brain.  >>>>​​​​​

Wei-Yu Chi is a medical doctor and current Ph.D. candidate at Weill Cornell Medicine, specializing in the development of single-cell sequencing technologies. With a focus on oncology, he is pioneering a novel sequencing method to profile transcription factor binding in single cells—a critical advance for understanding blood cancers such as leukemia and lymphoma and identifying potential drug targets. >>>>​​​

​​​​​

​

Fatemah Mukadum is a scientist and connector with a unique ability to bridge the gap between cutting-edge research and the business of life sciences, leveraging deep expertise in computational modeling and a keen eye for scientific innovation.

Fatemah is an NSF GRFP Fellow and PhD candidate in Chemistry at New York University, where she works with Professor Glen Hocky. >>>>​​​​​​​

​

Jake Rossetto is a scientist by training and a biotech operator specializing at the intersection of scientific innovation and commercialization. Currently, he is pursuing an MBA with a concentration in finance at Babson College, where he is formalizing his expertise in venture capital and corporate finance.  >>>>

​​​​

​​​​​

​​​

​